Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Facial WastingFacial Wasting
         
Rollover images to visit our other forums!
 
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Lipoatrophy from Truvada Norvir Reyataz?
Apr 1, 2009

I am taking Reyataz, Norvir and Truvada for 20 months. I found out I was positive and think I could have been so only around 9 months before knowing. My CD4 was 300-350 and went on meds I stated before a month later. I eat well, and live as I always have, a healthy life. I wanted to know your experience with Wasting/Lipoatrophy on this regimen. Is there a regimen that is better to avoid wasting/lipoatrophy?Does every regimen eventually cause Wasting/Lipoatrophy? thanks

Response from Dr. Pierone

Hello, and thanks for posting.

Truvada is the least likely of the nucleosides to produce lipoatrophy. Also, it is likely that Norvir and Reyataz may provide some partial protection against lipoatrophy because of the tendency for boosted protease inhibitors to produce some weight gain.

Lipoatrophy is not an inevitable consequence of antiretroviral treatment and some patients are fine after many years of older more toxic medications.

Some of the newer medications like raltegravir (Isentress) may be even less likely to produce lipoatrophy, although this remains to be proven.

Good luck!



  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement